Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06883396 · ClinicalTrials.gov registry record
JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligament Reconstruction
A clinical trial of Patellar Dislocation and Patellar Dislocation, Recurrent, sponsored by Hospital for Special Surgery, New York.
- Recruiting
- Registry status
- 850
- Enrollment target
- 16
- Study locations
NCT06883396: Recruiting study of Patellar Dislocation and Patellar Dislocation, Recurrent, sponsored by Hospital for Special Surgery, New York.
NCT06883396 is a study of Patellar Dislocation and Patellar Dislocation, Recurrent that is actively recruiting participants, run by Hospital for Special Surgery, New York. The registered enrollment target is 850 participants, above the 113-participant average among 3 other Patellar Dislocation trials with a reported enrollment target (652% higher). The trial reports 16 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06883396, a study of Patellar Dislocation and Patellar Dislocation, Recurrent, is actively recruiting participants, sponsored by Hospital for Special Surgery, New York.
- RECRUITING
- Registry status
- 850 participants
- Enrollment target
- 16
- Study locations
Study Summary
The goal of this observational study is to learn about the outcomes of medial patellofemoral ligament (MPFL) reconstruction for the treatment of recurrent patellar instability. The main questions it aims to answer are: * What are the risk factors for recurrent patellar instability after MPFL reconstruction? * What functional outcomes do patients report after MPFL reconstruction? Participants undergoing MPFL reconstruction will answer survey questions about their knee and activity level 1 year and 2 years after surgery.
Primary Outcome
Patient-reported patellar dislocation or subluxation
Conditions Studied
Interventions
- PROCEDURE Medial Patellofemoral Ligament (MPFL) Reconstruction
Study Locations (16)
New York
- Mount Sinai - New York
- NYU Langone Health - New York
- Hospital for Special Surgery - New York
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
- Cleveland Clinic - Cleveland
- Ohio State University Wexler Medical Center - Dublin
Massachusetts
- Massachusetts General Hospital - Boston
- Boston Children's Hospital - Boston
California
- Stanford University - Redwood City
Florida
- University of Florida - Gainesville
Illinois
- Midwest Orthopaedics at Rush - Chicago
Iowa
- University of Iowa - Iowa City
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 850 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2027-12 |
What NCT06883396 shows while recruiting
NCT06883396 is an observational study that tracks outcomes without assigning an intervention. The registered 850 participants enrollment target is mid-sized for trials with a published cap, above the 113-participant average among 3 other Patellar Dislocation trials with a reported enrollment target (652% higher).
The record links to 6 conditions, with Patellar Dislocation appearing as the primary indexed condition, and to 1 intervention - of which Medial Patellofemoral Ligament (MPFL) Reconstruction is the first listed.
NCT06883396 lists 16 locations in 11 states (New York, Ohio, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT06883396 about?
NCT06883396 is a clinical study titled "JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligament Reconstruction". The goal of this observational study is to learn about the outcomes of medial patellofemoral ligament (MPFL) reconstruction for the treatment of recurrent patellar instability. The main questions it aims to answer are: * What are the risk factors for recurrent patellar instability after MPFL recons...
What is the current status of trial NCT06883396?
This trial is currently recruiting. The enrollment target is 850 participants. The study started on 2023-01-01. Estimated completion is 2027-12.
What conditions does trial NCT06883396 study?
This clinical trial studies the following conditions: Patellar Dislocation, Patellar Dislocation, Recurrent, Patellar Instability, Patellofemoral Dislocation, Patellofemoral Joint Dislocation.
What interventions are being tested in trial NCT06883396?
The interventions under investigation include: Medial Patellofemoral Ligament (MPFL) Reconstruction (PROCEDURE).
Who is sponsoring clinical trial NCT06883396?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06883396 being conducted?
This trial has 16 study locations across California, Florida, Illinois, Iowa, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Patellar Dislocation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Blood Flow Restriction Training After Patellar INStability
RECRUITING · NA
-
Effect of Early Range of Motion Following First Time Patellar Dislocation
ACTIVE NOT RECRUITING · NA
-
The Impact of Tibial Tubercle-trochlear Groove Distance and Patellar Height on the Outcome of Isolated Medial Patellofemoral Ligament Reconstruction
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03507257 · 850 participants
Longitudinal Early-onset Alzheimer's Disease Study Protocol
- NCT05846841 · 850 participants · NA
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
- NCT05987059 · 850 participants · Phase 2
Involving Communities in Addressing the Maternal Health Crisis: Making an IMPACT
- NCT06289673 · 850 participants · Phase 4
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI